课题基金 / 基金详情

Recovery of vestibular function by intracochlear administration of various kinds of agents

Recovery of vestibular function by intracochlear administration of various kinds of agents
通过耳蜗内给药各种药物恢复前庭功能
批准号:
12671669
负责人:
SHIMOGORI Hiroaki
金额:
$1.54万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

SHIMOGORI Hiroaki的其他基金

相似基金

相关文献

中文摘要
翻译
研究了类固醇和ATP对前庭功能障碍豚鼠外周前庭系统的影响。手术切除右侧半规管,并抽吸淋巴液2秒。横切的两端用纤维蛋白胶密封。耳蜗切开术后,用渗透泵直接输注倍他米松或ATP。治疗前后行梯形旋转试验,在黑暗中用CCD摄像机记录旋转后眼球震颤,并进行分析。倍他米松和ATP均能显著改善损伤后旋转性眼球震颤的恢复。这些数据表明,急性前庭病变动物在耳蜗内给予类固醇和ATP可能导致前庭失衡的快速纠正前庭功能分析的建立设计了一种新的眼动图像分析技术。利用这种方法,我们可以计算出最大慢相速度。我们展示了旋转后眼震数与最大慢相速度之间的关系。此外,利用该技术,我们可以计算前庭-眼反射增益。各种药物对前庭功能的影响可以在不侵犯的情况下进行研究。
英文摘要
1 Drug effects on vestibular disorderEffects of steroid and ATP on peripheral vestibular system in guinea pig with vestibular disorder were investigated. The right lateral semicircular canal was surgically transected and lymph fluids were suctioned for two seconds. The transected ends were sealed with fibrin glue. After cochleotomy, betamethasone or ATP was directly infused into scala tympany with an osmotic pump. Before and after treatment, trapezoid rotation tests were performed and post-rotatory nystagmus was recorded on videotape with CCD camera in the dark, and was analyzed. Both betamethasone and ATP significantly improved post-rotatory nystagmus recovery after injury. These data indicates the possibility that intracochlear administration of steroid and ATP to animals with acute vestibular lesion may lead to rapid correction of vestibular imbalance.2 Establishment of vestibular function analysisA new eye movement image analysis technique was devised. With this technique, we can calculate maximum slow phase velocity. We have shown the relation between post-rotatory nystagmus number and maximum slow phase velocity. Furthermore, using this technique, we can calculate vestibulo-ocular reflex gain. Various kinds of drug effects on vestibular function can be investigated with no invasion.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
Shimogori,Hiroaki: "Evaluation of vestibular function in osmotic-pump implanted animals"Equilibrium Res. 59. 306-310 (2000)
Shimogori,Hiroaki:“渗透泵植入动物的前庭功能评估”平衡研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sugawara,Kazuma: "The role of acidic fibroblast growth factor in recovery of acoustic trauma"Neuro Report. 12. 3299-3302 (2001)
菅原和真:“酸性成纤维细胞生长因子在声损伤恢复中的作用”神经报告。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hiroaki Shimogori: "Efficacy of intracochlear administration of betamethasone on peripheral vestibular disorder in the guinea pig"Neuroscience Letters. 294. 21-24 (2000)
Hiroaki Shimogori:“倍他米松耳蜗内给药对豚鼠外周前庭疾病的功效”神经科学快报。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
13
    Antidepressant and vestibular plasticity
    • 批准号:
      23592484
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.5万
    • 财政年份:
      2011
    • 负责人:
      SHIMOGORI Hiroaki
    • 依托单位:
    Vestibular plasticity-a role of vestibular ganglion-
    • 批准号:
      20591984
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.33万
    • 财政年份:
      2008
    • 负责人:
      SHIMOGORI Hiroaki
    • 依托单位:
    Direct administration therapy for irreversible peripheral vestibular disorder
    • 批准号:
      14571621
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.6万
    • 财政年份:
      2002
    • 负责人:
      SHIMOGORI Hiroaki
    • 依托单位:
    国内基金
    海外基金
    SIRT4介导的ATP5β乙酰化修饰在血管平滑肌细胞衰老和腹主动脉瘤中的作用和机制研究
    • 批准号:
      2026JJ50331
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      袁昭顺
    • 依托单位:
    小分子化合物T-2307及其类似物通过PG-PMF-ATP通路抗MRSA感染的分子机制及应用研究
    《ATP13A2缺失通过调控星型胶质细胞外泌体miRNA货物分泌介导帕金森病 神经炎症的机制研究》
    • 批准号:
      2026JJ81265
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      尹翔安
    • 依托单位:
    ATP13A2介导HDAC6溶酶体定位在抑郁模型中的作用机制研究
    • 批准号:
      JCZRQNB202600165
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位: